Fibrocell Science, Inc. Deferred Tax Liabilities, Financing Arrangements
Fibrocell Science, Inc. had Deferred Tax Liabilities, Financing Arrangements of $2.84 million as of 2018-12-31, per its 10-K filed 2019-03-27.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesFinancingArrangements · last filed 2019-03-27
- 2018-12-31: Deferred Tax Liabilities, Financing Arrangements $2.84M.
- 2017-12-31: Deferred Tax Liabilities, Financing Arrangements $2.82M.
- 2016-12-31: Deferred Tax Liabilities, Financing Arrangements $4.26M.
- 2015-12-31: Deferred Tax Liabilities, Financing Arrangements $0.00.
| Period end | Deferred Tax Liabilities, Financing Arrangements |
|---|---|
| 2018-12-31 | $2.84M 10-K · filed 2019-03-27 |
| 2017-12-31 | $2.82M 10-K · filed 2019-03-27 |
| 2016-12-31 | $4.26M 10-K · filed 2018-03-19 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-09 |